Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Annals of the New York Academy of Sciences|January 11, 2013
TAP expression level in tumor cells defines the nature and processing of MHC class I peptides for recognition by tumor-specific cytotoxic T lymphocytesFaten El Hage, Aurélie Durgeau, Fathia Mami-ChouaibMedecine Sciences : M/S|September 12, 2006
[Immunotherapy of cancer: promise and reality]Salem Chouaib, Faten El Hage, Houssem Benlalam, et al.Bulletin Du Cancer|January 31, 2008
[Immune response and cancer]Faten El Hage, Soraya Abouzahr-Rifai, Franck Meslin, et al.Oncology Reports|August 4, 2005
Generation of diverse mutated tumor antigen-specific cytotoxic T lymphocytes in a lung cancer patient with long survivalFaten El Hage, Isabelle Vergnon, Dominique Grunenwald, et al.Proceedings of the National Academy of Sciences of the United States of America|July 16, 2008
Preprocalcitonin signal peptide generates a cytotoxic T lymphocyte-defined tumor epitope processed by a proteasome-independent pathwayFaten El Hage, Vincent Stroobant, Isabelle Vergnon, et al.Oncogene|October 17, 2003
Functional and molecular characterization of a KIR3DL2/p140 expressing tumor-specific cytotoxic T lymphocyte clone infiltrating a human lung carcinomaGuillaume Dorothée, Hamid Echchakir, Béatrice Le Maux Chansac, et al.Journal of Immunology (Baltimore, Md. : 1950)|October 26, 2011
Different expression levels of the TAP peptide transporter lead to recognition of different antigenic peptides by tumor-specific CTLAurélie Durgeau, Faten El Hage, Isabelle Vergnon, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 21, 2005
In situ sensory adaptation of tumor-infiltrating T lymphocytes to peptide-MHC levels elicits strong antitumor reactivityGuillaume Dorothée, Isabelle Vergnon, Faten El Hage, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 22, 2007
Human CD5 protects circulating tumor antigen-specific CTL from tumor-mediated activation-induced cell deathGrzegorz Friedlein, Faten El Hage, Isabelle Vergnon, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 7, 2009
The cooperative induction of hypoxia-inducible factor-1 alpha and STAT3 during hypoxia induced an impairment of tumor susceptibility to CTL-mediated cell lysisMuhammad Zaeem Noman, Stéphanie Buart, Jos Van Pelt, et al.Pageof 1